Journal: CytoJournal
Article Title: A novel candidate tumor biomarker progestin and adipoQ receptor 3 regulates cell metastasis through transforming growth factor-β pathway in hepatocellular carcinoma
doi: 10.25259/Cytojournal_138_2025
Figure Lengend Snippet: PAQR3 regulates HCC cell metastasis and ferroptosis through the TGF-b pathway. (a) Wound healing assay images showing cell migration in different groups (scale bars: 200 μm). (b) Quantification of cell migration rates from wound healing assay. (c) Transwell invasion assay images of HCC cells in different groups (scale bars: 50 μm). (d) Quantification of invaded cell counts from the Transwell assay. (e) Representative Western blot images of EMT-related proteins (E-cadherin, N-cadherin, Vimentin, b-actin). (f) Quantification of relative E-cadherin expression. (g) Quantification of relative N-cadherin expression. (h) Quantification of relative Vimentin expression. (i) TBARS assay showing lipid peroxidation levels. (j) C11-BODIPY staining showing ROS levels (merge, oxidized C11, non-oxidized C11, scale bars: 50 μm). (k) Representative images of intracellular Fe 2+ fluorescence (scale bars: 50 μm). (l) Quantification of red/green fluorescence ratio for ROS levels. (m) Quantification of intracellular Fe 2+ fluorescence intensity. (n) Representative western blot images of ferroptosis-related proteins (SLC7A11, GPX4, ACSL4, b-actin). (o) Quantification of relative SLC7A11 expression. (p) Quantification of relative GPX4 expression. (q) Quantification of relative ACSL4 expression. ✶ P < 0.05, ✶ ✶ P < 0.01, ✶ ✶ ✶ P < 0.001, ns: Not significant. Images in (a, c, e, j, k, n) are representative of three independent experiments. Quantitative data in (b, d, f-h, i, l, m, o-q) are presented as mean±SD from three independent experiments. PAQR3: Progestin and adipoQ receptor 3, HCC: Hepatocellular carcinoma, EMT: Epithelial-mesenchymal transition, TBARS: Thiobarbituric acid reactive substance, Oe-NC: Overexpression negative control.
Article Snippet: Lipid peroxidation in HCC cells following the indicated treatments was assessed using a TBARS Assay Kit (Elabscience Biotechnology Co., Ltd., E-BC-K298-M, Wuhan, Hubei, China).
Techniques: Wound Healing Assay, Migration, Transwell Invasion Assay, Transwell Assay, Western Blot, Expressing, TBARS Assay, Staining, Fluorescence, Over Expression, Negative Control